VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 397 filers reported holding VANECK VECTORS ETF TR in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $986,000 | +16.1% | 46,755 | +2.0% | 0.24% | +26.8% |
| Q3 2018 | $849,000 | -28.7% | 45,825 | -14.1% | 0.19% | -28.8% |
| Q2 2018 | $1,190,000 | +25.8% | 53,326 | +23.9% | 0.27% | +18.7% |
| Q1 2018 | $946,000 | +9.5% | 43,030 | +15.7% | 0.22% | +8.7% |
| Q4 2017 | $864,000 | +33.5% | 37,175 | +31.7% | 0.21% | +27.0% |
| Q3 2017 | $647,000 | +5.0% | 28,220 | +1.2% | 0.16% | -5.8% |
| Q2 2017 | $616,000 | -8.1% | 27,890 | -5.1% | 0.17% | -5.5% |
| Q1 2017 | $670,000 | +82.1% | 29,380 | +66.6% | 0.18% | +77.7% |
| Q4 2016 | $368,000 | -96.3% | 17,635 | -53.6% | 0.10% | -96.3% |
| Q3 2016 | $10,052,000 | – | 38,033 | – | 2.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |